Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 596 (LINC00596) is a human long non-coding RNA (lncRNA) gene located on chromosome 14 (14q11.2) and produces non-coding transcripts of approximately 900–940 base pairs[3][5][13]. It is also known by the synonyms C14orf165 and CNSLT1I7G[1][3][5][9][11][13]. LINC00596 is annotated as an intergenic RNA gene and does not encode a protein[3][5][13]. Its function is currently uncharacterized in detail, but lincRNAs as a group can regulate gene expression, typically by interacting with chromatin or transcriptional machinery, and are being investigated as potential regulators in various diseases, especially cancers[15]. There is presently no evidence or literature establishing LINC00596 as a direct therapeutic target or as a receptor, enzyme, transporter, or classical signaling molecule[1][3][5][7][9][11][13]. No drugs are known to specifically interact with LINC00596, and there are no recognized mechanisms of action, biomarkers, or safety concerns particular to this lncRNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 596 (LINC00596).